Image courtesy of MassMEDIC
Founders: Oriana Papin-Zoghbi, Anna Jeter, Alexander Fischer
Locations: Boston, New York, London
Web site: https://www.aoadx.com/
AOA is developing the first early-stage ovarian cancer blood test so a woman can quickly and accurately be tested to catch the disease earlier when survival rates are 90%. 94% of women with ovarian cancer experience symptoms but current standard of care takes 9 months to diagnose, leading to the majority of cases caught at stage 3 and 4 when survival rates are extremely low.